These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
627 related articles for article (PubMed ID: 18844286)
21. Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts. Kogan NM; Melamed E; Wasserman E; Raphael B; Breuer A; Stok KS; Sondergaard R; Escudero AV; Baraghithy S; Attar-Namdar M; Friedlander-Barenboim S; Mathavan N; Isaksson H; Mechoulam R; Müller R; Bajayo A; Gabet Y; Bab I J Bone Miner Res; 2015 Oct; 30(10):1905-13. PubMed ID: 25801536 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia. Ryan D; Drysdale AJ; Pertwee RG; Platt B Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463 [TBL] [Abstract][Full Text] [Related]
23. The Pharmacological Basis of Cannabis Therapy for Epilepsy. Reddy DS; Golub VM J Pharmacol Exp Ther; 2016 Apr; 357(1):45-55. PubMed ID: 26787773 [TBL] [Abstract][Full Text] [Related]
24. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Bergamaschi MM; Queiroz RH; Zuardi AW; Crippa JA Curr Drug Saf; 2011 Sep; 6(4):237-49. PubMed ID: 22129319 [TBL] [Abstract][Full Text] [Related]
25. Constituents of Cannabis Sativa. Rock EM; Parker LA Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000 [TBL] [Abstract][Full Text] [Related]
26. Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment. Premoli M; Aria F; Bonini SA; Maccarinelli G; Gianoncelli A; Pina SD; Tambaro S; Memo M; Mastinu A Life Sci; 2019 May; 224():120-127. PubMed ID: 30910646 [TBL] [Abstract][Full Text] [Related]
27. Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats. Murillo-Rodríguez E; Palomero-Rivero M; Millán-Aldaco D; Mechoulam R; Drucker-Colín R Life Sci; 2011 Mar; 88(11-12):504-11. PubMed ID: 21262236 [TBL] [Abstract][Full Text] [Related]
28. Anticonvulsant activity of four oxygenated cannabidiol derivatives. Carlini EA; Mechoulam R; Lander N Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):1-15. PubMed ID: 1188178 [TBL] [Abstract][Full Text] [Related]
29. Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol. Bielawiec P; Harasim-Symbor E; Chabowski A Front Endocrinol (Lausanne); 2020; 11():114. PubMed ID: 32194509 [TBL] [Abstract][Full Text] [Related]
30. Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluation. Klein M; de Quadros De Bortolli J; Guimarães FS; Salum FG; Cherubini K; de Figueiredo MAZ Phytother Res; 2018 Nov; 32(11):2275-2281. PubMed ID: 30088305 [TBL] [Abstract][Full Text] [Related]
31. Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. Farrimond JA; Mercier MS; Whalley BJ; Williams CM Phytother Res; 2011 Feb; 25(2):170-88. PubMed ID: 21213357 [TBL] [Abstract][Full Text] [Related]
32. Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats. Perez M; Benitez SU; Cartarozzi LP; Del Bel E; Guimarães FS; Oliveira AL Eur J Neurosci; 2013 Nov; 38(10):3424-34. PubMed ID: 23981015 [TBL] [Abstract][Full Text] [Related]
33. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We? Lippiello P; Balestrini S; Leo A; Coppola A; Citraro R; Elia M; Russo E; De Sarro G Curr Pharm Des; 2016; 22(42):6426-6433. PubMed ID: 27587196 [TBL] [Abstract][Full Text] [Related]
34. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Russo E; Guy GW Med Hypotheses; 2006; 66(2):234-46. PubMed ID: 16209908 [TBL] [Abstract][Full Text] [Related]
35. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Russo EB; Guy GW; Robson PJ Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817 [TBL] [Abstract][Full Text] [Related]
36. The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease. Kicman A; Toczek M Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937917 [TBL] [Abstract][Full Text] [Related]
37. Cannabidiol in medical marijuana: Research vistas and potential opportunities. Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518 [TBL] [Abstract][Full Text] [Related]
38. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease. Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623 [TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of standardized cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility. Capasso R; Aviello G; Borrelli F; Romano B; Ferro M; Castaldo L; Montanaro V; Altieri V; Izzo AA Urology; 2011 Apr; 77(4):1006.e9-1006.e15. PubMed ID: 21310467 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol. Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]